Supha Pharmachem Limited (BOM:539561)
0.3100
-0.0100 (-3.13%)
At close: Jul 10, 2026
Supha Pharmachem Market Cap
Supha Pharmachem has a market cap or net worth of 124.99 million as of July 10, 2026. Its market cap has decreased by -81.66% in one year.
Market Cap
124.99M
Enterprise Value
10.99B
Revenue
5.27B
Ranking
n/a
PE Ratio
1.66
Stock Price
0.31
Market Cap Chart
Since May 25, 2018, Supha Pharmachem's market cap has increased from 45.36M to 124.99M, an increase of 175.56%. That is a compound annual growth rate of 13.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 124.99M | -58.67% |
| Dec 31, 2025 | 302.40M | -85.35% |
| Dec 31, 2024 | 2.06B | -79.58% |
| Dec 29, 2023 | 10.11B | 1,895.62% |
| Dec 30, 2022 | 506.52M | 1.22% |
| Dec 31, 2021 | 500.40M | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.43B |
| Smruthi Organics | 1.39B |
| Tyche Industries | 1.25B |
| Krebs Biochemicals & Industries | 1.22B |
| Vasundhara Rasayans | 553.01M |
| Bacil Pharma | 550.58M |
| Crestchem | 382.95M |
| Alfavision Overseas (India) | 325.35M |